Last 12 months
Inside the activity.
0 purchase rows · 49 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 13 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 11 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 11 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 14 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 22, 2021 Filed Dec 22, 2021 21:00 UTC |
Legault PierreDirector
|
SaleOrdinary Shares | 97,860 | $58.01 | $5,676,858.60 |
DisclosureSEC source: 0001209191-21-071007 · doc4.xml · nonDerivative · entry 6 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.51 to $58.50 inclusive. Read SEC document |
| December 22, 2021 Filed Dec 22, 2021 21:00 UTC |
Legault PierreDirector
|
Exercise / conversionOrdinary Shares | 97,860 | $8.48 | $829,852.80 |
DisclosureSEC source: 0001209191-21-071007 · doc4.xml · nonDerivative · entry 5 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,860 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.331495 to GBP 1.00 as of December 22, 2021. Read SEC document |
| December 21, 2021 Filed Dec 22, 2021 21:01 UTC |
Keen NicholasChief Scientific Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 15,477 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-071008 · doc4.xml · derivative · entry 2 Keen Nicholas · CIK 0001776881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,927 Underlying: Ordinary Shares · 15,477 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| December 21, 2021 Filed Dec 22, 2021 21:01 UTC |
Keen NicholasChief Scientific Officer
|
Exercise / conversionOrdinary Shares | 15,477 | $14.00 | $216,678.00 |
DisclosureSEC source: 0001209191-21-071008 · doc4.xml · nonDerivative · entry 1 Keen Nicholas · CIK 0001776881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,477 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 21, 2021 Filed Dec 22, 2021 21:00 UTC |
Legault PierreDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 44,537 | $0.00 Strike: $8.44 | $0.00 |
DisclosureSEC source: 0001209191-21-071007 · doc4.xml · derivative · entry 8 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 121,172 Underlying: Ordinary Shares · 44,537 shares Expires 2029-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.324735 to GBP 1.00 as of December 21, 2021. F8 · derivative.exercise_date: This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022. Read SEC document |
| December 21, 2021 Filed Dec 22, 2021 21:00 UTC |
Legault PierreDirector
|
SaleOrdinary Shares | 44,537 | $57.11 | $2,543,508.07 |
DisclosureSEC source: 0001209191-21-071007 · doc4.xml · nonDerivative · entry 4 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.02 to $57.55 inclusive. Read SEC document |
| December 21, 2021 Filed Dec 22, 2021 21:00 UTC |
Legault PierreDirector
|
Exercise / conversionOrdinary Shares | 44,537 | $8.44 | $375,892.28 |
DisclosureSEC source: 0001209191-21-071007 · doc4.xml · nonDerivative · entry 3 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,537 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.324735 to GBP 1.00 as of December 21, 2021. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 21:00 UTC |
Legault PierreDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,603 | $0.00 Strike: $8.41 | $0.00 |
DisclosureSEC source: 0001209191-21-071007 · doc4.xml · derivative · entry 7 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,709 Underlying: Ordinary Shares · 7,603 shares Expires 2029-04-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.319915 to GBP 1.00 as of December 20, 2021. F8 · derivative.exercise_date: This option shall vest in 36 equal monthly installments and shall be fully vested on March 15, 2022. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 21:00 UTC |
Legault PierreDirector
|
SaleOrdinary Shares | 7,603 | $57.02 | $433,523.06 |
DisclosureSEC source: 0001209191-21-071007 · doc4.xml · nonDerivative · entry 2 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $57.00 to $57.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (5) and (7). Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 21:00 UTC |
Legault PierreDirector
|
Exercise / conversionOrdinary Shares | 7,603 | $8.41 | $63,941.23 |
DisclosureSEC source: 0001209191-21-071007 · doc4.xml · nonDerivative · entry 1 Legault Pierre · CIK 0001391045 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,603 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.319915 to GBP 1.00 as of December 20, 2021. Read SEC document |
| October 18, 2021 Filed Oct 18, 2021 22:22 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 49 | $60.00 | $2,940.00 |
DisclosureSEC source: 0001209191-21-060745 · doc4.xml · nonDerivative · entry 3 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,085 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| October 15, 2021 Filed Oct 18, 2021 22:22 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 320 | $60.05 | $19,216.00 |
DisclosureSEC source: 0001209191-21-060745 · doc4.xml · nonDerivative · entry 2 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,134 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.10 inclusive. Read SEC document |
| October 14, 2021 Filed Oct 18, 2021 22:22 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 4,631 | $60.00 | $277,860.00 |
DisclosureSEC source: 0001209191-21-060745 · doc4.xml · nonDerivative · entry 1 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,454 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.06 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 21:28 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 598 | $54.67 | $32,692.66 |
DisclosureSEC source: 0001209191-21-060383 · doc4.xml · nonDerivative · entry 2 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,085 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $54.24 to $55.51 inclusive. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 21:28 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 4,402 | $53.77 | $236,695.54 |
DisclosureSEC source: 0001209191-21-060383 · doc4.xml · nonDerivative · entry 1 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,683 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $53.23 to $54.22 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). Read SEC document |
| October 05, 2021 Filed Oct 5, 2021 16:16 UTC |
Keen NicholasChief Scientific Officer
|
SaleOrdinary Shares | 2,178 | $45.10 | $98,227.80 |
DisclosureSEC source: 0001209191-21-059375 · doc4.xml · nonDerivative · entry 2 Keen Nicholas · CIK 0001776881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.52 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 16:16 UTC |
Keen NicholasChief Scientific Officer
|
SaleOrdinary Shares | 1,188 | $45.00 | $53,460.00 |
DisclosureSEC source: 0001209191-21-059375 · doc4.xml · nonDerivative · entry 1 Keen Nicholas · CIK 0001776881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,178 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 23, 2021 Filed Sep 27, 2021 20:53 UTC |
Smethurst DominicChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 6,000 | $0.00 Strike: $18.55 | $0.00 |
DisclosureSEC source: 0001209191-21-057789 · doc4.xml · derivative · entry 2 Smethurst Dominic · CIK 0001820549 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,000 Underlying: Ordinary Shares · 6,000 shares Expires 2030-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: This option vested one-fourth (1/4) of the total number of shares on August 10, 2021 and the remaining shares shall vest or vested in 36 equal monthly installments at the end of each calendar month thereafter. Read SEC document |
| September 23, 2021 Filed Sep 27, 2021 20:53 UTC |
Smethurst DominicChief Medical Officer
|
Exercise / conversionOrdinary Shares | 6,000 | $18.55 | $111,300.00 |
DisclosureSEC source: 0001209191-21-057789 · doc4.xml · nonDerivative · entry 1 Smethurst Dominic · CIK 0001820549 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 16, 2021 Filed Sep 17, 2021 16:47 UTC |
Keen NicholasChief Scientific Officer
|
SaleOrdinary Shares | 1,955 | $45.01 | $87,994.55 |
DisclosureSEC source: 0001209191-21-056655 · doc4.xml · nonDerivative · entry 2 Keen Nicholas · CIK 0001776881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,366 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.105 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 16:47 UTC |
Keen NicholasChief Scientific Officer
|
SaleOrdinary Shares | 3,000 | $45.00 | $135,000.00 |
DisclosureSEC source: 0001209191-21-056655 · doc4.xml · nonDerivative · entry 1 Keen Nicholas · CIK 0001776881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,321 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 16:47 UTC |
Keen NicholasChief Scientific Officer
|
SaleOrdinary Shares | 10,000 | $40.00 | $400,000.00 |
DisclosureSEC source: 0001209191-21-054789 · doc4.xml · nonDerivative · entry 1 Keen Nicholas · CIK 0001776881 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,321 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:46 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 5,000 | $40.00 | $200,000.00 |
DisclosureSEC source: 0001209191-21-054787 · doc4.xml · nonDerivative · entry 5 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,085 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:49 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $9.82 | $0.00 |
DisclosureSEC source: 0001209191-21-054792 · doc4.xml · derivative · entry 3 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 10,000 shares Expires 2030-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F2 · derivative.exercise_date: This option shall vest one-fourth (1/4) of the total number of shares under option on January 2, 2021 and the remaining shares in 36 equal monthly installments at the end of each calendar month thereafter. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:49 UTC |
Kalowski LeePresident and CFO
|
SaleOrdinary Shares | 10,000 | $40.00 | $400,000.00 |
DisclosureSEC source: 0001209191-21-054792 · doc4.xml · nonDerivative · entry 2 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 02, 2021 Filed Sep 3, 2021 20:49 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionOrdinary Shares | 10,000 | $9.82 | $98,200.00 |
DisclosureSEC source: 0001209191-21-054792 · doc4.xml · nonDerivative · entry 1 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:46 UTC |
Lee KevinDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 22,890 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054787 · doc4.xml · derivative · entry 6 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,252 Underlying: Ordinary Shares · 22,890 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:46 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 1,796 | $38.08 | $68,391.68 |
DisclosureSEC source: 0001209191-21-054787 · doc4.xml · nonDerivative · entry 4 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,085 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to $38.255 inclusive. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:46 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 17,098 | $37.52 | $641,516.96 |
DisclosureSEC source: 0001209191-21-054787 · doc4.xml · nonDerivative · entry 3 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,881 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.99 inclusive. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:46 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 8,191 | $36.38 | $297,988.58 |
DisclosureSEC source: 0001209191-21-054787 · doc4.xml · nonDerivative · entry 2 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 258,979 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.975 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4). Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 20:46 UTC |
Lee KevinDirector · Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 22,890 | $14.00 | $320,460.00 |
DisclosureSEC source: 0001209191-21-054787 · doc4.xml · nonDerivative · entry 1 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 267,170 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 31, 2021 Filed Aug 31, 2021 21:29 UTC |
Lee KevinDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,420 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054118 · doc4.xml · derivative · entry 7 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 329,142 Underlying: Ordinary Shares · 10,420 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| August 31, 2021 Filed Aug 31, 2021 21:29 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 1,272 | $37.08 | $47,165.76 |
DisclosureSEC source: 0001209191-21-054118 · doc4.xml · nonDerivative · entry 5 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 244,280 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.58 inclusive. Read SEC document |
| August 31, 2021 Filed Aug 31, 2021 21:29 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 9,953 | $36.23 | $360,597.19 |
DisclosureSEC source: 0001209191-21-054118 · doc4.xml · nonDerivative · entry 4 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,552 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.86 inclusive. Read SEC document |
| August 31, 2021 Filed Aug 31, 2021 21:29 UTC |
Lee KevinDirector · Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 10,420 | $14.00 | $145,880.00 |
DisclosureSEC source: 0001209191-21-054118 · doc4.xml · nonDerivative · entry 3 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 255,505 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 27, 2021 Filed Aug 27, 2021 22:31 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,950 | $0.00 Strike: $8.73 | $0.00 |
DisclosureSEC source: 0001209191-21-053710 · doc4.xml · derivative · entry 6 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,768 Underlying: Ordinary Shares · 7,950 shares Expires 2029-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.3709 to GBP 1.00 as of August 27, 2021. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F6 · derivative.exercise_date: 25% of the shares vested on January 1, 2020, and the remaining vested or shall vest in 36 equal monthly installments. Read SEC document |
| August 27, 2021 Filed Aug 27, 2021 22:31 UTC |
Kalowski LeePresident and CFO
|
SaleOrdinary Shares | 7,950 | $35.15 | $279,442.50 |
DisclosureSEC source: 0001209191-21-053710 · doc4.xml · nonDerivative · entry 4 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.08 to $35.18 inclusive. Read SEC document |
| August 27, 2021 Filed Aug 27, 2021 22:31 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionOrdinary Shares | 7,950 | $8.73 | $69,403.50 |
DisclosureSEC source: 0001209191-21-053710 · doc4.xml · nonDerivative · entry 3 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F4 · price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.3709 to GBP 1.00 as of August 27, 2021. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 21:29 UTC |
Lee KevinDirector · Chief Executive Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,808 | $0.00 Strike: $14.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054118 · doc4.xml · derivative · entry 6 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,562 Underlying: Ordinary Shares · 1,808 shares Expires 2029-06-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option shall vest in 36 equal monthly installments at the end of each calendar month following the date of the grant. Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 21:29 UTC |
Lee KevinDirector · Chief Executive Officer
|
SaleOrdinary Shares | 1,808 | $36.02 | $65,124.16 |
DisclosureSEC source: 0001209191-21-054118 · doc4.xml · nonDerivative · entry 2 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 245,085 F1 · kind: Shares sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.20 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4). Read SEC document |
| August 27, 2021 Filed Aug 31, 2021 21:29 UTC |
Lee KevinDirector · Chief Executive Officer
|
Exercise / conversionOrdinary Shares | 1,808 | $14.00 | $25,312.00 |
DisclosureSEC source: 0001209191-21-054118 · doc4.xml · nonDerivative · entry 1 Lee Kevin · CIK 0001776938 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 246,893 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 22:31 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 550 | $0.00 Strike: $8.76 | $0.00 |
DisclosureSEC source: 0001209191-21-053710 · doc4.xml · derivative · entry 5 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,718 Underlying: Ordinary Shares · 550 shares Expires 2029-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.374675 to GBP 1.00 as of August 26, 2021. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F6 · derivative.exercise_date: 25% of the shares vested on January 1, 2020, and the remaining vested or shall vest in 36 equal monthly installments. Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 22:31 UTC |
Kalowski LeePresident and CFO
|
SaleOrdinary Shares | 550 | $35.04 | $19,272.00 |
DisclosureSEC source: 0001209191-21-053710 · doc4.xml · nonDerivative · entry 2 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.01 to $35.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) and (5). Read SEC document |
| August 26, 2021 Filed Aug 27, 2021 22:31 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionOrdinary Shares | 550 | $8.76 | $4,818.00 |
DisclosureSEC source: 0001209191-21-053710 · doc4.xml · nonDerivative · entry 1 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F2 · price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.374675 to GBP 1.00 as of August 26, 2021. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 21:45 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 7,500 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0001209191-21-053350 · doc4.xml · derivative · entry 3 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,774 Underlying: Ordinary Shares · 7,500 shares Expires 2027-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.366815 to GBP 1.00 as of August 23, 2021. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F4 · derivative.exercise_date: 20% of the shares subject to the option vested on July 24, 2018, 60% of the shares subject to the option will vest each month thereafter in 36 equal monthly installments, and the remaining 20% of the shares subject to the option will vest on the earlier of (i) the fourth anniversary of the grant date and (ii) the date on which the Issuer's board of directors determines that the Issuer has satisfied certain performance vesting milestones, in all cases provided that the Reporting Person remains continuously employed with us through each applicable vesting date. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 21:45 UTC |
Kalowski LeePresident and CFO
|
SaleOrdinary Shares | 7,500 | $33.02 | $247,650.00 |
DisclosureSEC source: 0001209191-21-053350 · doc4.xml · nonDerivative · entry 2 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.056 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 23, 2021 Filed Aug 25, 2021 21:45 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionOrdinary Shares | 7,500 | $1.60 | $12,000.00 |
DisclosureSEC source: 0001209191-21-053350 · doc4.xml · nonDerivative · entry 1 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F2 · price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.366815 to GBP 1.00 as of August 23, 2021. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 22:21 UTC |
Kalowski LeePresident and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $1.63 | $0.00 |
DisclosureSEC source: 0001209191-21-048919 · doc4.xml · derivative · entry 5 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,274 Underlying: Ordinary Shares · 12,500 shares Expires 2027-07-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: This exercise price is in US Dollars and reflects the conversion of GBP to USD at an exchange rate of $1.39511 to GBP 1.00 as of July 29, 2021. F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F6 · derivative.exercise_date: 20% of the shares subject to the option vested on July 24, 2018, 60% of the shares subject to the option will vest each month thereafter in 36 equal monthly installments, and the remaining 20% of the shares subject to the option will vest on the earlier of (i) the fourth anniversary of the grant date and (ii) the date on which the Issuer's board of directors determines that the Issuer has satisfied certain performance vesting milestones, in all cases provided that the Reporting Person remains continuously employed with us through each applicable vesting date. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 22:21 UTC |
Kalowski LeePresident and CFO
|
SaleOrdinary Shares | 300 | $32.81 | $9,843.00 |
DisclosureSEC source: 0001209191-21-048919 · doc4.xml · nonDerivative · entry 4 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.78 to $32.86 inclusive. Read SEC document |
| July 29, 2021 Filed Jul 30, 2021 22:21 UTC |
Kalowski LeePresident and CFO
|
SaleOrdinary Shares | 3,204 | $32.13 | $102,944.52 |
DisclosureSEC source: 0001209191-21-048919 · doc4.xml · nonDerivative · entry 3 Kalowski Lee · CIK 0001618273 · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300 F1 · kind: Shares exercised and sold pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.77 to $32.76 inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.